Alice Lhabouz, CE and founder of Trecento AM, comments on Challenges news from the Swiss giant Novartis, and also the announcement of Varant Narasimhan, CEO of the company since February. “The group will focus on specialty pharma, personalized medicine and rare diseases with growth and higher margins, enough to reallocate capital and increase the (…)” Read…
Alice Lhabouz, President and Founder of Trecento AM, comments on Challenges the stock market performance of semiconductor manufacturer STMicroelectronics. “The growth in revenues and margins in the first quarter shows that the restructuring of STMicroelectronics is well underway.The company has offset the weakness of the business” smartphones “(and iPhone in particular) by a sustained activity…
While awaiting the clinical results of potentially promising drugs in the treatment of Alzheimer’s disease, the Trecento AM team comments on Challenges the decision of Agnès Buzyn to change the patient care path. “Even if the drug reassures, the challenge today is to change attitudes by ending the only drug to highlight the (…)” Read…
Christophe Pouchoy, Managing Director and General Manager, co-manager of the Trecento Santé fund, answered Pharmaceutical magazine’s questions about the growth and profitability of the pharmaceutical and biotech sector. He also explained the favorable impact for the US tax reform sector. “For big pharma, which has a significant turnover in the US market, the largest in…
Challenges magazine interviewed Alice Lhabouz, President and Founder of Trecento AM, about the non-prescription drug (“OTC”) market and its recent mergers and acquisitions. “The catalysts for the growth of this market are mainly of a demographic nature: the continuous aging of the world population, the prolongation of the life span, especially in developed countries, (…)”…
Trecento AM delivers, in the magazine Express, its impressions of the Consumer Electronics Show. The CES is the biggest event dedicated to technological innovations where the “French Tech” demonstrated its know-how. “Health is a promising theme, linked to demographic changes such as the aging of the population (which leads to increased needs for personal assistance services)…
President and founder of Trecento AM and Trecento Groupe, Alice Lhabouz is also President of the My Block Fund association. Read the portrait of this passionate woman entrepreneur by clicking here (available in French only)
The magazine Challenges asked the CEO and founder of Trecento AM, Alice Lhabouz, about the pharmaceutical giant Sanofi, which recorded the biggest drop in the Paris index for 6 months. “The fourth quarter 2017 of Sanofi has disappointed, and foreshadows a complicated first half of 2018. The decline of the diabetes segment will continue, (…)”…
“With 3-digit growth, Trecento AM is positioning itself for the second year in a row as the top growth champion. Focus on a company led by Alice Lhabouz, which lacks neither ambition nor talent.” Read the article by clicking here (available in French only)
Trecento AM informs the unitholders of CHF shares (FR0013224409) and USD shares (FR0013224391) of the Trecento Santé fund that the calculation period for outperformance fees is changed. The initial period ran from January 17, 2017, when these units were created, to January 17, 2018. The end-of-period date is extended to December 31, 2018, the new…
